Drug Trial Radar · NCT01197053
Epicutaneous Immunotherapy in Peanut Allergy in Children
Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Aug 2010
Primary completion
Feb 2015
Study completion Apr 2015
Sponsor
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- DBV Technologies; URC-CIC Paris Descartes Necker Cochin
- First posted
- Sep 9, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 5 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims at showing that Epicutaneous Immunotherapy with peanut proteins is safe and efficacious for desensitizing children with peanut allergy.
Conditions
- Peanut Allergy
Interventions
Epicutaneous ImmunotherapyBiological
100 mcg peanut proteins (active arm) applied on the skin every 24 hrs for 6 months blinded, followed by 12 months open treatment for all patients in the active arm
placebo of peanutBiological
placebo applied on the skin every 24 hrs for 6 months blinded, followed by 12 months open treatment for all patients in the active arm
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients able to consume >1000 mg of peanut proteins symptom-freeTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hopital Necker
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.